Met de zogeheten ikHerstel-app herstellen patiënten aanzienlijk van grote buikoperaties dan patiënten die de app niet gebruiken. Het herstel duurt nog maar 7 in plaats van 9 weken. Met de app ervaren patiënten meer eigen regie door zelf actief aan hun herstel te werken. Daardoor wordt ook het zorgpersoneel ontlast.
NewsDemonstrator Lab was celebrating their successes with the Demonstrator Lab’s Summer Pitch Event on June 22nd. Out of a total of 21 pre-finalists, 6 projects made it to pitch their idea to an expert jury in the finals. Madglove, Pulse and VU-AMS won the competition and were each awarded EUR 1.000 vouchers to be spent […]
NewsTopics that you will see this year are most definitely novel uses of AI, for instance in academia and in health, clever notions on how to deal with the effects of climate change, inspiring solutions in medical care technology, ideas about solving mental health issues, and innovative plans for improving education.
NewsFrom 4-9 June, IXA attended the BIO International Convention in Boston, aiming for global partnerships. The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. A team of six business developers from both the Amsterdam UMC and Vrije Universiteit Amsterdam had 87 […]
NewsAt Amsterdam’s Roeterseiland Campus (REC) a Hub will arise, dedicated to cultivating a culture of impact learning, research, innovation, and valorisation.
NewsIkHerstel, an app that helps patients recover after surgery, is getting a capital injection by CbusineZ – the investment arm of health insurer CZ, together with investment company Healthy Capital.
NewsMadglove, a participant in the Demonstrator Lab at VU Amsterdam, has clinched the top spot at the ASIF P!tch XL event, marking a significant milestone in their mission to revolutionize the field of rehabilitation.
NewsFitsurance is intensifying the development of the digital health platform 3D lifestyle Coaching that counters chronic diseases through generating personal lifestyle advice.
NewsPhotosynthetic & Veridis, two VU start-ups, are part of the Pole Position Programme #4 by Techleap. Through the programme, like-minded industry experts who will guide the founders of Photosynthetic & Veridis on their journey towards becoming global leaders and take Pole Position. Techleap is a government funded organization to connect and empower startups to grow and sustain a productive tech community.
NewsPhlox, a private biotechnology spin-off from Amsterdam UMC and specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies, has secured additional seed funding to advance Phlox’s lead program aimed at rare genetic laminopathies.
News